Purchase Order 12349B19P0005
- Not listed
- The U.S. civilian federal government awarded a $3,500 firm fixed-price purchase order for DNA sequencing services to Psomagen Inc., a genomics and molecular biology services company based in Rockville, Maryland and subsidiary of Macrogen, Inc. The contract, awarded on April 10, 2018, with performance to be completed by the same date, represents a ratifying order with no small business set-aside designation. Work is to be performed in Potomac, Maryland. Psomagen specializes in advanced genomic...
- The U.S. government awarded a $12.5K firm fixed-price purchase order to Psomagen Inc. for sequencing services on April 15, 2016. The contract, which was not designated as a set-aside, was funded by a civilian agency within the Southeast Area and required performance in Potomac, Maryland, with an ultimate completion date of September 30, 2017. Psomagen Inc., a genomics and molecular biology services company based in Rockville, Maryland, and a subsidiary of Macrogen Inc., provided the sequencing...
- This federal contract represents a ratifying order for sequencing services awarded to Psomagen Inc., a genomics and molecular biology services company subsidiary of Macrogen, Inc., on April 10, 2018. The purchase order carries a ceiling value of $2,718.65 under a firm fixed-price contract type with no set-aside designation. The work will be performed in Potomac, Maryland, and is funded by a civilian federal agency's Southeast Area office. Psomagen specializes in advanced genomic sequencing,...
- The U.S. federal government awarded a $31,368 purchase order to Psomagen Inc., a genomics and molecular biology services company headquartered in Rockville, Maryland, for Illumina High-Seq 2x150bp sequencing services generating gigabase output per lane. The contract, awarded on September 6, 2019, with an ultimate completion date of September 20, 2019, was issued without set-aside designation and was funded through a civilian federal agency's Southeast Area office. Work was performed at a...
- The National Heart, Lung and Blood Institute awarded a purchase order to Psomagen Inc. for $33,223.00 on February 28, 2017, for DNA sequencing services. Ultimate completion was February 27, 2018. Work is performed at North Bethesda, Maryland. The order carries firm fixed price terms and no small business set-aside. Psomagen is a for-profit genomics and molecular biology services company and a subsidiary of Macrogen, Inc., operating CLIA-certified and CAP-accredited facilities that provide...
- This is a firm-fixed-price purchase order awarded by the Southeast Area of a civilian federal agency to Psomagen Inc., a small business and subsidiary of Macrogen, Inc. The $9,370.00 contract is for soil microbe sequencing services, with a performance period ending on August 9, 2024. Psomagen is a provider of advanced genomic and molecular biology services, including capabilities in whole genome sequencing, RNA sequencing, epigenome sequencing, and microarray analysis. The company has...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $10,000.00 firm fixed-price purchase order is for DNA sequencing services. The contract has no set-aside designation. Psomagen Inc. is a provider of genomic and molecular biology services, including whole genome sequencing, RNA sequencing, and epigenome sequencing, that supports...
- This is a firm fixed-price purchase order awarded by the National Institute of Mental Health (NIMH), a civilian agency, to Psomagen Inc., a genomics and molecular biology services company based in Rockville, Maryland. The $180,000 contract has a period of performance ending on May 19, 2025. Psomagen Inc. is a subsidiary of the parent company Macrogen, Inc., which is a leading provider of genomic sequencing and bioinformatics services to the U.S. federal government. The contract does not have a...
- The U.S. Department of Agriculture Agricultural Research Service awarded a $40,116 firm fixed price purchase order to Psomagen Inc., a small business genomics services provider based in Rockville, Maryland, for Illumina Eukaryotic RNA Sequencing services on 288 samples. The contract, designated as a Total Small Business set-aside, was awarded on August 30, 2023, with an ultimate completion date of February 29, 2024, and will be performed in Potomac, Maryland. The solicitation, posted on August...
- The U.S. Food and Drug Administration (FDA) awarded a $19,380 firm fixed-price purchase order for whole genome sequencing services on the Illumina NovaSeq X platform to Psomagen Inc., a small business contractor. The contract has a completion date of September 19, 2025. Psomagen is a subsidiary of Macrogen, Inc. and operates CLIA-certified and CAP-accredited facilities to provide genomic sequencing, bioinformatics, and related services to federal agencies. This award is a small business...
The U.S. government awarded a $9,220 firm fixed-price purchase order to Psomagen Inc. for DNA library preparation and sequencing services, including additional quality control for replacement samples. The contract was set aside for small businesses and awarded on February 13, 2019, with an ultimate completion date of June 21, 2019. Work is being performed in Potomac, Maryland, and the funding agency is identified as the Northeast Area civilian federal agency component. Psomagen Inc., a genomics and molecular biology services company based in Rockville, Maryland and subsidiary of Macrogen Inc., specializes in advanced genomic sequencing and bioinformatics services. The company operates CLIA-certified and CAP-accredited facilities and serves as a key provider of genomic research services across multiple federal agencies, including the National Institutes of Health, Department of Agriculture, and Food and Drug Administration. This purchase order represents routine sequencing support consistent with Psomagen's portfolio of federal genomic service contracts, which range from approximately $10,000 to over $500,000 in value across various research domains including infectious diseases, precision medicine, and agricultural genetics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | $300 | 3/26/19 | |
| Not listed | Not listed | $8.9k | 2/13/19 |